| Literature DB >> 30381458 |
Joseph Sarhan1,2,3, Beiyun C Liu1,3, Hayley I Muendlein3,4, Peng Li5, Rachael Nilson3, Amy Y Tang3, Anthony Rongvaux6, Stephen C Bunnell3, Feng Shao5, Douglas R Green7, Alexander Poltorak8,9.
Abstract
Cell death and inflammation are intimately linked during Yersinia infection. Pathogenic Yersinia inhibits the MAP kinase TGFβ-activated kinase 1 (TAK1) via the effector YopJ, thereby silencing cytokine expression while activating caspase-8-mediated cell death. Here, using Yersinia pseudotuberculosis in corroboration with costimulation of lipopolysaccharide and (5Z)-7-Oxozeaenol, a small-molecule inhibitor of TAK1, we show that caspase-8 activation during TAK1 inhibition results in cleavage of both gasdermin D (GSDMD) and gasdermin E (GSDME) in murine macrophages, resulting in pyroptosis. Loss of GsdmD delays membrane rupture, reverting the cell-death morphology to apoptosis. We found that the Yersinia-driven IL-1 response arises from asynchrony of macrophage death during bulk infections in which two cellular populations are required to provide signal 1 and signal 2 for IL-1α/β release. Furthermore, we found that human macrophages are resistant to YopJ-mediated pyroptosis, with dampened IL-1β production. Our results uncover a form of caspase-8-mediated pyroptosis and suggest a hypothesis for the increased sensitivity of humans to Yersinia infection compared with the rodent reservoir.Entities:
Keywords: TAK1; Yersinia; caspase-8; gasdermin; pyroptosis
Mesh:
Substances:
Year: 2018 PMID: 30381458 PMCID: PMC6243247 DOI: 10.1073/pnas.1809548115
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205